Screener
Eton Pharmaceuticals, Inc. ETON Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtCurrent.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $13,485 | $10,976 |
| Short-term debt, net of debt discount | 11,808 | 8,789 |
| Accrued Medicaid rebates | 11,140 | 9,317 |
| Accrued liabilities | 7,746 | 9,408 |
| Total current liabilities | 44,179 | 38,490 |
| Long-term debt, net of current portion and debt discount | 18,939 | 21,769 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s current debt?
- Eton Pharmaceuticals, Inc. (ETON) reported current debt of $11.81M in Q1 2026.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s current debt?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s current debt has grown at a 59.6% compound annual growth rate (CAGR), from $849K to $8.79M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Eton Pharmaceuticals, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude